REGENXBIO(RGNX) - 2024 Q1 - Quarterly Results

REGENXBIO Reports First Quarter 2024 Financial Results and Recent Operational Highlights ROCKVILLE, Md., May 8, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced financial results for the first quarter ending March 31, 2024. Recent operational highlights, including acceleration of the prioritized pipeline supports meaningful value generation from the Company's strong portfolio of AAV Therapeutics. "Exciting program and data updates continue in 2024 and demonstrate remarkable progress on how ...